1. Home
  2. PFSA vs PRPH Comparison

PFSA vs PRPH Comparison

Compare PFSA & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSA
  • PRPH
  • Stock Information
  • Founded
  • PFSA 2009
  • PRPH 1989
  • Country
  • PFSA United States
  • PRPH United States
  • Employees
  • PFSA N/A
  • PRPH N/A
  • Industry
  • PFSA Medical/Dental Instruments
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFSA Health Care
  • PRPH Health Care
  • Exchange
  • PFSA Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • PFSA 25.1M
  • PRPH 21.9M
  • IPO Year
  • PFSA N/A
  • PRPH 1997
  • Fundamental
  • Price
  • PFSA $0.29
  • PRPH $0.39
  • Analyst Decision
  • PFSA
  • PRPH
  • Analyst Count
  • PFSA 0
  • PRPH 0
  • Target Price
  • PFSA N/A
  • PRPH N/A
  • AVG Volume (30 Days)
  • PFSA 2.3M
  • PRPH 1.6M
  • Earning Date
  • PFSA 11-20-2025
  • PRPH 11-12-2025
  • Dividend Yield
  • PFSA N/A
  • PRPH N/A
  • EPS Growth
  • PFSA N/A
  • PRPH N/A
  • EPS
  • PFSA N/A
  • PRPH N/A
  • Revenue
  • PFSA $75,000.00
  • PRPH $5,588,000.00
  • Revenue This Year
  • PFSA N/A
  • PRPH $221.82
  • Revenue Next Year
  • PFSA N/A
  • PRPH N/A
  • P/E Ratio
  • PFSA N/A
  • PRPH N/A
  • Revenue Growth
  • PFSA 7.14
  • PRPH N/A
  • 52 Week Low
  • PFSA $0.26
  • PRPH $0.22
  • 52 Week High
  • PFSA $5.50
  • PRPH $2.44
  • Technical
  • Relative Strength Index (RSI)
  • PFSA N/A
  • PRPH 40.56
  • Support Level
  • PFSA N/A
  • PRPH $0.45
  • Resistance Level
  • PFSA N/A
  • PRPH $0.54
  • Average True Range (ATR)
  • PFSA 0.00
  • PRPH 0.06
  • MACD
  • PFSA 0.00
  • PRPH -0.02
  • Stochastic Oscillator
  • PFSA 0.00
  • PRPH 12.43

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: